Evidence map›Paper›PMID 35891457›Full record

ArticleViruses2022

Vaccine Mismatches, Viral Circulation, and Clinical Severity Patterns of Influenza B Victoria and Yamagata Infections in Brazil over the Decade 2010-2020: A Statistical and Phylogeny-Trait Analyses.

Jaline Cabral da Costa, Marilda Mendonça Siqueira, David Brown, Jonathan Oliveira Lopes, Braulia Caetano da Costa, Eric Lopes Gama, Maria de Lourdes Aguiar-Oliveira

Abstract read
In one paragraph

Article in Viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Severity of Clinical Presentation and Outcomes in Hospitalized Adult People With Influenza by Type and Subtype, United States-2017-2020.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jaline Cabral da CostaLaboratory of Respiratory Virus and Measles, Oswaldo Cruz Institute, Oswaldo Cruz Foundation. Av. Brasil, 4365 Manguinhos, Rio de Janeiro 21040-360, RJ, Brazil.ORCID 0000-0002-9108-4419
Marilda Mendonça SiqueiraLaboratory of Respiratory Virus and Measles, Oswaldo Cruz Institute, Oswaldo Cruz Foundation. Av. Brasil, 4365 Manguinhos, Rio de Janeiro 21040-360, RJ, Brazil.
David BrownLaboratory of Respiratory Virus and Measles, Oswaldo Cruz Institute, Oswaldo Cruz Foundation. Av. Brasil, 4365 Manguinhos, Rio de Janeiro 21040-360, RJ, Brazil.
Jonathan Oliveira LopesLaboratory of Respiratory Virus and Measles, Oswaldo Cruz Institute, Oswaldo Cruz Foundation. Av. Brasil, 4365 Manguinhos, Rio de Janeiro 21040-360, RJ, Brazil.
Braulia Caetano da CostaLaboratory of Respiratory Virus and Measles, Oswaldo Cruz Institute, Oswaldo Cruz Foundation. Av. Brasil, 4365 Manguinhos, Rio de Janeiro 21040-360, RJ, Brazil.ORCID 0000-0002-1373-8966
Eric Lopes GamaLaboratory of Respiratory Virus and Measles, Oswaldo Cruz Institute, Oswaldo Cruz Foundation. Av. Brasil, 4365 Manguinhos, Rio de Janeiro 21040-360, RJ, Brazil.
Maria de Lourdes Aguiar-OliveiraLaboratory of Respiratory Virus and Measles, Oswaldo Cruz Institute, Oswaldo Cruz Foundation. Av. Brasil, 4365 Manguinhos, Rio de Janeiro 21040-360, RJ, Brazil.ORCID 0000-0002-2472-5263

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Worldwide, infections by influenza viruses are considered a major public health challenge. In this study, influenza B vaccine mismatches and clinical aspects of Victoria and Yamagata infections in Brazil were assessed. Clinical samples were collected from patients suspected of influenza infection. In addition, sociodemographic, clinical, and epidemiological information were collected by the epidemiological surveillance teams. Influenza B lineages were determined by real-time RT-PCR and/or Sanger sequencing. In addition, putative phylogeny−trait associations were assessed by using the BaTS program after phylogenetic reconstruction by a Bayesian Markov Chain Monte Carlo method (BEAST software package). Over 2010−2020, B/Victoria and B/Yamagata-like lineages co-circulated in almost all seasonal epidemics, with B/Victoria predominance in most years. Vaccine mismatches between circulating viruses and the trivalent vaccine strains occurred in five of the eleven seasons (45.5%). No significant differences were identified in clinical presentation or disease severity caused by both strains, but subjects infected by B/Victoria-like viruses were significantly younger than their B/Yamagata-like counterparts (16.7 vs. 31.4 years, p < 0.001). This study contributes to a better understanding of the circulation patterns and clinical outcomes of B/Victoria- and B/Yamagata-like lineages in Brazil and advocate for the inclusion of a quadrivalent vaccine in the scope of the Brazilian National Immunization Program.

Indexed as

Influenza, HumanInfluenza VaccinesBayes TheoremBrazilHumansInfluenza B virusPhylogenyInfluenza Vaccinesclinical diseaseinfluenza B lineagesphylogeneticsphylogeny–trait associationvaccine mismatch

Identifiers

PMID35891457
PMCPMC9321334

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.